Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Presentations

Corporate Presentation

Download the Presentation

AASLD Presentation 11/13/2023

Download the Presentation

AASLD Poster 11/13/2023

Download the Presentation

LPCN 1154 Topline Results - PK Bridge Clinical Study

Download the Presentation

LPCN 1144 Presentation-OLE Topline Results

Download the Presentation

LPCN 1144 Presentation-LiFT Topline 36 Week Results

Download the Presentation

LPCN 1144 LiFT 12 Week Study Results

Download the Presentation

LPCN 1148 Presentation

Download the Presentation

LPCN 1148 Phase 2 Study Topline Results

Download the Presentation

LPCN 1144 Presentation

Download the Presentation